3.0.0 1327 2023-01-11T13:31:08Z 2023-01-11T13:31:08Z Senate S 2015-05-13 114 ssju00 Judiciary Committee Senate Standing Referred to 2015-05-13T18:57:53Z Synthetic Abuse and Labeling of Toxic Substances Act of 2015 114 1186 HR 2015-03-31 Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations. Related bill CRS 2015-05-13 ssju00 Judiciary Committee Senate Read twice and referred to the Committee on the Judiciary. IntroReferral 2015-05-13 Introduced in Senate IntroReferral 10000 9 Library of Congress K000367 Sen. Klobuchar, Amy [D-MN] Amy Klobuchar D MN N G000359 Sen. Graham, Lindsey [R-SC] Lindsey Graham R SC 2015-05-13 True F000062 Sen. Feinstein, Dianne [D-CA] Dianne Feinstein D CA 2015-05-13 True G000386 Sen. Grassley, Chuck [R-IA] Charles Grassley R IA E. 2015-05-13 True B001277 Sen. Blumenthal, Richard [D-CT] Richard Blumenthal D CT 2016-07-11 False T000476 Sen. Tillis, Thomas [R-NC] Thomas Tillis R NC Roland 2016-07-11 False C001056 Sen. Cornyn, John [R-TX] John Cornyn R TX 2016-09-26 False W000802 Sen. Whitehouse, Sheldon [D-RI] Sheldon Whitehouse D RI 2016-09-26 False Crime and Law Enforcement Drug trafficking and controlled substances Drug, alcohol, tobacco use Evidence and witnesses Marketing and advertising Crime and Law Enforcement 00 2015-05-13 Introduced in Senate 2015-07-28T19:57:24Z Synthetic Abuse and Labeling of Toxic Substances Act of 2015 or the SALTS Act

Amends the Controlled Substances Act to authorize evidence related to the following factors to be considered in determining whether a controlled substance analogue was intended for human consumption:

  • the marketing, advertising, and labeling of the substance;
  • the known efficacy or usefulness of the substance for the marketed, advertised, or labeled purpose;
  • the difference between the price at which the substance is sold and the price at which the substance it is purported to be or advertised as is normally sold;
  • the diversion of the substance from legitimate channels and the clandestine importation, manufacture, or distribution of the substance; and
  • whether the defendant knew or should have known that the substance was intended to be consumed by injection, inhalation, ingestion, or any other immediate means.

Declares that the existence of evidence that a substance was not marketed, advertised, or labeled for human consumption shall not preclude the government from establishing, based on all the evidence, that the substance was intended for human consumption.

]]> Synthetic Abuse and Labeling of Toxic Substances Act of 2015 Display Title Synthetic Abuse and Labeling of Toxic Substances Act of 2015 Official Title as Introduced A bill to amend the Controlled Substances Act relating to controlled substance analogues. Introduced in Senate IS Short Titles as Introduced Synthetic Abuse and Labeling of Toxic Substances Act of 2015 Short Titles as Introduced SALTS Act Introduced in Senate 2015-05-13T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-114s1327is/xml/BILLS-114s1327is.xml 2015-05-13 Read twice and referred to the Committee on the Judiciary. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.